FDA asks drugmaker to stop selling its opioid painkiller

FDA asks drugmaker to stop selling its opioid painkiller


U.S. regulators want a narcotic painkiller involved in the opioid epidemic off the market amid data showing people continue to abuse it. The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER, after concluding the drugs's risks outweigh its benefits.



from Biotech News